Alexandre Reuben

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinationsPreprint

  Research Square · 2026-06-19

• Deciphering small sequence differences in T cell receptor-antigen pairing

  Nature Communications · 2026-06-13

• Abstract 6989: RBM10 loss promotes <i>KRAS</i> -mutant non-small cell lung cancer immune tolerance and PD-1 inhibitor resistance via a non-canonical STING/ NF-κB axis

  Cancer Research · 2026-04-03

• Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichmentPreprint

  arXiv (Cornell University) · 2026-01-08

• Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichment

  ArXiv.org · 2026-01-08

• Deciphering Small Sequence Differences in T Cell Receptor-Antigen Pairing

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-01

• PP01.23/OA07.01: Myeloid IL-1 Signaling Drives The Precancer-to-Cancer Evolution of Human Pulmonary Nodules

  Journal of Thoracic Oncology · 2026-01-01 · 1 citations

• Deciphering Small Sequence Differences in T Cell Receptor-Antigen Pairing

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-01

• Editor’s Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

  Cancer Discovery · 2025-12-02

• 368 Time-lapse analysis of TCR-T cells highlights heterogeneity and kinetics of responses upon antigen stimulation

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

  European Urology · 2025-07-31 · 22 citations

• Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma

  npj Precision Oncology · 2025-07-01 · 2 citations

• Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

  Journal for ImmunoTherapy of Cancer · 2025-06-01 · 5 citations

• Clinical and Fundamental Research Progressions on Tumor-Infiltrating Lymphocytes Therapy in Cancer

  Vaccines · 2025-05-14 · 2 citations

• Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

  Cancer Cell · 2025-05-08 · 28 citations

• Abstract 2366: Dynamic crosstalk between endothelial and epithelial cells drives tumor progression in lung adenocarcinoma

  Cancer Research · 2025-04-21

• Abstract 6424: Harnessing circulating neoantigen-specific T cells for immune surveillance and cancer prevention in Lynch syndrome

  Cancer Research · 2025-04-21

• A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma

  Neuro-Oncology · 2025-03-17 · 8 citations

• Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

  Nature Communications · 2025-02-24

• Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): Primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives.

  Journal of Clinical Oncology · 2025-02-10 · 4 citations